Neuritis
MONDO:0002122A neuropathy arising from inflammation of one or more nerves.
Also known as: nerve inflammation
34 clinical trials for this condition and its sub-types, 18 tagged with Neuritis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Neuritis
-
Vestibular neuronitis 9 trials
-
Polyneuritis 3 trials
-
Brachial plexus neuritis 0 trials
1 sub-type
- Radial nerve lesion 0 trials
-
Mononeuritis simplex 0 trials
2 sub-types
- Mononeuritis of lower limb 0 trials Sub-types →
- Upper limb mononeuronitis 0 trials
-
Motor nerve neuritis 0 trials
1 sub-type
- Asymmetric motor neuropathy 0 trials
-
Neuritis of upper limb 0 trials
3 sub-types
- Mononeuritis multiplex 0 trials
- Radial nerve lesion 0 trials
- Upper limb mononeuronitis 0 trials
-
Neuroretinitis 0 trials
Most studied deeper sub-types
-
New combo therapy targets nerve pain in rare blood cancers
Disease control OngoingThis study tests whether combining acalabrutinib with rituximab is safe and effective for people with nerve damage (neuropathy) linked to two blood conditions: IgM MGUS or Waldenstrom macroglobulinemia. The main goal is to see if the treatment lowers a key protein (IgM) in the bl…
Phase 2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for chemo pain: nerve zap study launches
Symptom relief OngoingThis study tests a treatment called neuromodulation to see if it can reduce nerve pain caused by chemotherapy. About 24 adults with nerve pain in their legs from certain chemo drugs will take part. Researchers will check for side effects and measure changes in pain and nerve func…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Soundwave therapy shows promise for chemo nerve damage
Symptom relief OngoingThis study tests a device called SensoniQ® Treatment Station that uses low frequency soundwaves to prevent or reduce nerve pain caused by chemotherapy in people with gynecologic cancer. The trial includes 80 participants, some starting chemo and others with lasting nerve pain. Re…
Sponsor: Augusta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New pain relief for diabetic nerves? trial pulled before start
Symptom relief CancelledThis study was designed to test a new drug called N0750 against two standard pain medications (Cymbalta and Lyrica) for painful diabetic peripheral neuropathy. It planned to enroll adults with diabetes and nerve pain for at least 3 months. However, the trial was withdrawn before …
Phase 3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC